Correction to: Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration.
Författaruppgift saknas
Am J Health Syst Pharm · published erratum · DOI 10.1093/ajhp/zxad325 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för xacduro. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
16 träffar<i>In vitro</i> activity of sulbactam-durlobactam against colistin-resistant and/or cefiderocol-non-susceptible, carbapenem-resistant <i>Acinetobacter baumannii</i> collected in U.S. hospitals.
Iovleva A, McElheny CL, Fowler EL, Cober E, Herc ES, Arias CA, Hill C, Baum K, Fowler VG, Chambers HF, Greenwood-Quaintance KE, Patel R, van Duin D, Bonomo RA, Doi Y.
Antimicrob Agents Chemother · brief-report; journal article; research support, n.i.h., extramural · DOI 10.1128/aac.01258-23Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration.
Ruiz VH, Shen Y, Abouelhassan Y, Fouad A, Nicolau DP, Kuti JL.
Am J Health Syst Pharm · research support, non-u.s. gov't; journal article · DOI 10.1093/ajhp/zxad232Sulbactam-Durlobactam, A Novel Drug for the Treatment of Multidrug Resistant <i>Acinetobacter baumannii</i> Infections - A Systematic Review.
Velmurugan H, Venkatesan S, Meles HN, Neelambaram K, Thangaraju P.
Infect Disord Drug Targets · systematic review; journal article · DOI 10.2174/0118715265276432231217192054Sulbactam-durlobactam susceptibility test method development and quality control ranges for MIC and disk diffusion tests.
McLeod SM, Carter NM, Huband MD, Traczewski MM, Bradford PA, Miller AA.
J Clin Microbiol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/jcm.01228-23Cefiderocol and Sulbactam-Durlobactam against Carbapenem-Resistant <i>Acinetobacter baumannii</i>.
Karruli A, Migliaccio A, Pournaras S, Durante-Mangoni E, Zarrilli R.
Antibiotics (Basel) · review-article; review; journal article · DOI 10.3390/antibiotics12121729<i>In vivo</i> dose response and efficacy of the β-lactamase inhibitor, durlobactam, in combination with sulbactam against the <i>Acinetobacter baumannii-calcoaceticus</i> complex.
O'Donnell J, Tanudra A, Chen A, Newman J, McLeod SM, Tommasi R.
Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.00800-23<b><i>I</i></b> <i>n vitro</i> pharmacokinetics/pharmacodynamics of the β-lactamase inhibitor, durlobactam, in combination with sulbactam against <i>Acinetobacter baumannii-calcoaceticus</i> complex.
O'Donnell J, Tanudra A, Chen A, Miller AA, McLeod SM, Tommasi R.
Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.00312-23Sulbactam/Durlobactam.
Beninger P.
Clin Ther · editorial · DOI 10.1016/j.clinthera.2023.11.009In vitro synergy of the combination of sulbactam-durlobactam and cefepime at clinically relevant concentrations against A. baumannii, P. aeruginosa and Enterobacterales.
Fouad A, Nicolau DP, Gill CM.
J Antimicrob Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1093/jac/dkad244Sulbactam/durlobactam (Xacduro) for Acinetobacter pneumonia.
Författaruppgift saknas
Med Lett Drugs Ther · journal article · DOI 10.58347/tml.2023.1690cMolecular drivers of resistance to sulbactam-durlobactam in contemporary clinical isolates of <i>Acinetobacter baumannii</i>.
Moussa SH, Shapiro AB, McLeod SM, Iyer R, Carter NM, Tsai Y-K, Siu LK, Miller AA.
Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.00665-23Sulbactam-Durlobactam in the Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infections.
August B, Matlob A, Kale-Pradhan PB.
Ann Pharmacother · review; journal article · DOI 10.1177/10600280231204566Sulbactam/Durlobactam: First Approval.
Keam SJ.
Drugs · review; journal article · DOI 10.1007/s40265-023-01920-6Sulbactam and Durlobactam
Författaruppgift saknas
Tidskrift saknas · reviewSalvage therapy with sulbactam/durlobactam against cefiderocol-resistant <i>Acinetobacter baumannii</i> in a critically ill burn patient: clinical challenges and molecular characterization.
Tiseo G, Giordano C, Leonildi A, Riccardi N, Galfo V, Limongi F, Nicastro M, Barnini S, Falcone M.
JAC Antimicrob Resist · research-article; journal article · DOI 10.1093/jacamr/dlad078